Highlights
- Sales over the Year and quarter: The company experienced a substantial growth of 4.27 % in the past year, substantial increase in net sales/revenue by 12.72 %.
- Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 174.32 %. Marginal increase in other income during this quarter, up by 46.04%.
- Profit over the Year and quarter: Significant improvement in profitability for Aarti Pharmalabs Limited. Notable increase of 52.21 % in net profit Year to Year, Aarti Pharmalabs Limited’s profitability increased by 23.67 % in this quarter.
- EPS over the Year and quarter: EPS increased by 52.22 % Year to Year. EPS increased by 23.71 % in previous quarter. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 485.06 Cr | Rs. 448.689 Cr | Rs. 505.767 Cr | + 12.72 % | + 4.27 % |
| Expenses | Rs. 405.07 Cr | Rs. 353.01 Cr | Rs. 388.25 Cr | + 9.98 % | -4.15 % |
| Operating Profit | Rs. 79.99 Cr | Rs. 95.68 Cr | Rs. 117.52 Cr | + 22.83 % | + 46.92 % |
| OPM % | 16.49 % | 21.32 % | 23.24 % | + 1.92 % | + 6.75 % |
| Other Income | Rs. 0.74 Cr | Rs. 1.39 Cr | Rs. 2.03 Cr | + 46.04 % | + 174.32 % |
| Interest | Rs. 5.94 Cr | Rs. 4.48 Cr | Rs. 4.68 Cr | + 4.46 % | -21.21 % |
| Depreciation | Rs. 15.95 Cr | Rs. 18.77 Cr | Rs. 19.12 Cr | + 1.86 % | + 19.87 % |
| Profit before tax | Rs. 58.84 Cr | Rs. 73.82 Cr | Rs. 95.75 Cr | + 29.71 % | + 62.73 % |
| Tax % | 27.14 % | 28.52 % | 31.85 % | + 3.33 % | + 4.71 % |
| Net Profit | Rs. 42.87 Cr | Rs. 52.76 Cr | Rs. 65.25 Cr | + 23.67 % | + 52.2 % |
| EPS in Rs | Rs. 4.73 | Rs. 5.82 | Rs. 7.2 | + 23.71 % | + 52.22 % |
Today, we’re looking at Aarti Pharmalabs Limited’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 4.27 %. However, it did see a marginal increase of 12.72 % from the previous quarter. Expenses ticked up slightly by 9.98 % quarter-on-quarter, aligning with the annual decline of -4.15 %. Operating profit, while up 46.92 % compared to last year, faced a quarter-on-quarter increase of 22.83 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 6.75 %, but an expansion of 1.92 % sequentially. Other income rose by 46.04 % compared to the last quarter, despite an annual growth of 174.32 %. Interest expenses surged remarkably by 4.46 % from the previous quarter, yet the year-over-year decrease remains at a moderate -21.21 %. Depreciation costs climbed by 1.86 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 19.87 %. Profit before tax grew annually by 62.73 % but saw an increase from the preceding quarter by 29.71 %.
Tax expenses as a percentage of profits increased slightly by 4.71 % compared to last year, with a more notable quarter-on-quarter increase of 3.33 %. Net profit rose by 52.2 % year-on-year but experienced a 23.67 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 52.22 % but a quarterly rise of 23.71 %. In summary, Aarti Pharmalabs Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 485.06 Cr | Rs. 448.689 Cr | Rs. 505.767 Cr | + 12.72 % | + 4.27 % |
| Expenses | Rs. 405.07 Cr | Rs. 353.01 Cr | Rs. 388.25 Cr | + 9.98 % | -4.15 % |
| Operating Profit | Rs. 79.99 Cr | Rs. 95.68 Cr | Rs. 117.52 Cr | + 22.83 % | + 46.92 % |
| Net Profit | Rs. 42.87 Cr | Rs. 52.76 Cr | Rs. 65.25 Cr | + 23.67 % | + 52.2 % |
| EPS in Rs | Rs. 4.73 | Rs. 5.82 | Rs. 7.2 | + 23.71 % | + 52.22 % |
In reviewing Aarti Pharmalabs Limited’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 4.27 % year-on-year growth, however, there was a minor increase of 12.72 % from the previous quarter. Expenses decreased by -4.15 % compared to the previous year, with a 9.98 % increase quarter-on-quarter. Operating Profit surged by 46.92 % annually, and saw a 22.83 % increase from the last quarter.
Net Profit showed yearly increase of 52.2 %, and experienced a 23.67 % increase from the previous quarter. Earnings Per Share (EPS) rose by 52.22 % annually, however rose by 23.71 % compared to the last quarter. In essence, while Aarti Pharmalabs Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
